⚠️ Research Use Only. This post is educational and does not constitute medical advice. All peptides discussed are sold for research purposes only. See our full disclaimer.
Overview
MGF is a splice variant of IGF-1 produced in response to muscle damage, studied for satellite cell activation and localized muscle repair.
What is MGF?
Mechano Growth Factor (MGF) is a splice variant of IGF-1 that is produced locally in muscle tissue in response to mechanical loading and damage. It was identified in the late 1990s by researchers studying why exercised muscle expressed a different form of IGF-1 than systemic IGF-1.
The distinct feature of MGF is its E-domain, which appears to have biological activity independent of the IGF-1 receptor. Research suggests this E-domain plays a primary role in activating muscle satellite cells — the resident stem cells of muscle tissue responsible for repair and growth. Native MGF has an extremely short half-life of only a few minutes, which led to the development of PEG-MGF, a PEGylated version with hours-long activity.
Research dosing typically cites 100-200 mcg locally injected post-training, with the rationale being that MGF should be present during the window when satellite cells are being activated by mechanical loading. The clinical research base is thin — most published data comes from in vitro and animal studies, with limited human work.
MGF is sometimes positioned as superior to IGF-1 LR3 for muscle hypertrophy because of the satellite cell activation mechanism. The honest assessment is that the research isn't strong enough to make that claim with confidence — both peptides have potential mechanisms that look interesting on paper, and both have limited human data.
Top Research Uses
- Localized muscle repair
- Satellite cell activation
- Hypertrophy research
- Recovery from injury
Mechanism of Action
IGF-1 splice variant that activates satellite cells and promotes muscle fiber regeneration through unique non-receptor-mediated effects
Research Parameters
| Half-Life | Very short, ~5-7 minutes; PEG-MGF variants extend this dramatically |
| Typical Research Dose | Research protocols cite 100-200 mcg locally post-training |
| Administration Route | Subcutaneous, intramuscular (often local) |
| Reported Side Effects | Injection site reactions; theoretical hypoglycemia risk lower than IGF-1 LR3 due to short half-life |
Dosing ranges cited from published research literature. These are not recommendations for human use. MGF is a research compound — not for human consumption.
Research Strength: Low-Moderate
MGF has a small but growing body of research. Most evidence is preclinical with limited human data.
Vendor & Sourcing Notes
PEGylated version (PEG-MGF) is more commonly sold for its extended half-life
Always request third-party HPLC purity reports and mass spectrometry verification when sourcing research peptides. Quality varies significantly between suppliers.
Research Use Only — Compliance Notice
The information on this page is intended for educational and informational purposes only. MGF (Mechano Growth Factor) is a research compound sold for laboratory research purposes only. It has not been approved by the FDA for human use. Nothing on this page constitutes medical advice or is intended to diagnose, treat, cure, or prevent any disease. Statements have not been evaluated by the FDA. Consult a qualified healthcare professional before considering any peptide-related protocols.
